摘要
目的:探讨分析不同手术方式植入羟基磷石灰义眼台的临床疗效及临床应用价值。方法:以2005年3月至2011年4月接受羟基磷灰石义眼台植入的35例患者作为临床资料,根据患者的病情分为I期植入26例,II期植入9例,术后对患者进行3~36个月的随访,并比较观察患者术后并发症以及美容效果。结果:术后早期均有不同程度的眼痛,结膜水肿,适当处理后可逐渐消退,但II期植入持续时间较I期植入长,术后主要的并发症为义眼台暴露。对患者术后义眼台活动度进行测量,优(80%)、良(11.4%)、差(8.6%)。结论:I期植入与II期植入相比具有更好的临床疗效,所以应尽早手术治疗。术后主要的并发症是义眼台暴露。羟基磷灰石义眼台植入是一种安全、高效的眼部整容方式,具有较好的治疗效果,临床上值得推广应用。
Objective To explore and evaluate the effect of different hydroxyapatite(HA) implantation. Methods 35 hydroxyapatite implantation patients from April 2011 to April 2013 were selected as clinical data,According to the patient's condition is divided into stage I implanted( 26 cases),stage II implanted ( 9 cases),the total patients were observed and follow-up from three months to 36 months. Results Early postoperative varying degrees of eye pain, conjunctival edema, after appropriate treatment can be gradually subsided, but II implantation duration longer than that I implantation, major complications after surgery for implant exposure. Postoperative patients with severe active orbital measurements,excellent (80%),good (11.4%), and poor (8.6%). Conclusion Phase I and Phase II implants compared to implants with better clinical efficacy,so should be surgical treatment as early as possible.Major postoperative complications is exposed to the eye. Hydroxyapatite implantation is a safe and efficient way of eye surgery, has good treatment effect, worthy of clinical application.
出处
《中国美容医学》
CAS
2015年第6期18-20,共3页
Chinese Journal of Aesthetic Medicine
关键词
羟基磷灰石义眼台
眼科整容
疗效观察
hydroxyapatite prosthesis
ophthalmic plastic surgery
clinical observation